US 8247420
Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
granted A61PA61P25/00A61P25/18
Quick answer
US patent 8247420 (Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents) held by REVIVA PHARMACEUTICALS, INC. expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REVIVA PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P25/00, A61P25/18, A61P25/24